Natasha Petry

21PUBLICATIONS
59CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 26, 2026
Factors Facilitating Adoption of Pharmacogenetic Testing by Prescribers of Antidepressants in Four US Health Systems: A Multi-Site Cross-Sectional PGx Implementation Science Study.

|Aug 17, 2026
Tramadol Co-Administration with Oxycodone or Hydrocodone Increases Opioid Burden without Improving Postoperative Pain Control.

|Aug 10, 2026
Prompt Engineering of Large Language Models for Medication Dose Calculation.

|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population.

|Mar 09, 2026
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System.

Kristen Jacobsen, Natasha J Petry, Max Weaver

|Jun 20, 2024
Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition.

Nina R Sperber, Megan C Roberts, Sarah Gonzales

Pageof 4

Frequent Collaborators

4 joint publications

Jordan F Baye

4 joint publications

Amanda Massmann

4 joint publications

Laura Ramsey

3 joint publications

Nina R Sperber